中国免疫学杂志
中國免疫學雜誌
중국면역학잡지
CHINESE JOURNAL OF IMMUNOLOGY
2014年
12期
1658-1661
,共4页
陈俊%张伟%翁秀芳%陆盛军%吴雄文%梁智辉
陳俊%張偉%翁秀芳%陸盛軍%吳雄文%樑智輝
진준%장위%옹수방%륙성군%오웅문%량지휘
PBMC%器官移植%异种移植%移植物抗宿主病
PBMC%器官移植%異種移植%移植物抗宿主病
PBMC%기관이식%이충이식%이식물항숙주병
PBMC%Organ transplantation%Xenotransplantation%Graft versus host disease
目的:摸索X-GVHD模型的合适小鼠品系,建立稳定的“人-鼠”X-GVHD模型。方法:选取了裸鼠、NOD/SCID经亚致死剂量γ射线全身照射后,腹腔输注健康人外周血单核细胞( PBMC)建立异种X-GVHD模型。通过检测人T细胞在模型鼠外周血、组织、器官中的浸润情况等指标(采用流式细胞术和免疫组化技术),比较两种模型鼠中人免疫细胞的浸润率和各组生存时间,从而确定建立X-GVHD模型的合适小鼠品系,并摸索人PBMC的输注途径和合适细胞量,以及观察免疫细胞表型变化与功能的最佳时间窗口。结果:NOD/SCID鼠更适合诱导“人-鼠”X-GVHD模型的小鼠;腹腔输注途径和尾静脉输注途径对建立“人-鼠”X-GVHD模型无明显差异;腹腔输注5×107以上人PBMC可以成功建立“人-鼠”X-GVHD模型。在采用优化后的实验条件建立模型中,监测人T细胞表型动态变化与功能的最佳时间窗口为7~11 d;模型鼠的平均生存时间为(14.16±1.77)d。结论:NOD/SCID鼠通过腹腔注射5×107以上人PBMC可以成功建立“人-鼠”X-GVHD模型,7~11 d为监测人T细胞表型动态变化与功能的最佳时间。
目的:摸索X-GVHD模型的閤適小鼠品繫,建立穩定的“人-鼠”X-GVHD模型。方法:選取瞭裸鼠、NOD/SCID經亞緻死劑量γ射線全身照射後,腹腔輸註健康人外週血單覈細胞( PBMC)建立異種X-GVHD模型。通過檢測人T細胞在模型鼠外週血、組織、器官中的浸潤情況等指標(採用流式細胞術和免疫組化技術),比較兩種模型鼠中人免疫細胞的浸潤率和各組生存時間,從而確定建立X-GVHD模型的閤適小鼠品繫,併摸索人PBMC的輸註途徑和閤適細胞量,以及觀察免疫細胞錶型變化與功能的最佳時間窗口。結果:NOD/SCID鼠更適閤誘導“人-鼠”X-GVHD模型的小鼠;腹腔輸註途徑和尾靜脈輸註途徑對建立“人-鼠”X-GVHD模型無明顯差異;腹腔輸註5×107以上人PBMC可以成功建立“人-鼠”X-GVHD模型。在採用優化後的實驗條件建立模型中,鑑測人T細胞錶型動態變化與功能的最佳時間窗口為7~11 d;模型鼠的平均生存時間為(14.16±1.77)d。結論:NOD/SCID鼠通過腹腔註射5×107以上人PBMC可以成功建立“人-鼠”X-GVHD模型,7~11 d為鑑測人T細胞錶型動態變化與功能的最佳時間。
목적:모색X-GVHD모형적합괄소서품계,건립은정적“인-서”X-GVHD모형。방법:선취료라서、NOD/SCID경아치사제량γ사선전신조사후,복강수주건강인외주혈단핵세포( PBMC)건립이충X-GVHD모형。통과검측인T세포재모형서외주혈、조직、기관중적침윤정황등지표(채용류식세포술화면역조화기술),비교량충모형서중인면역세포적침윤솔화각조생존시간,종이학정건립X-GVHD모형적합괄소서품계,병모색인PBMC적수주도경화합괄세포량,이급관찰면역세포표형변화여공능적최가시간창구。결과:NOD/SCID서경괄합유도“인-서”X-GVHD모형적소서;복강수주도경화미정맥수주도경대건립“인-서”X-GVHD모형무명현차이;복강수주5×107이상인PBMC가이성공건립“인-서”X-GVHD모형。재채용우화후적실험조건건립모형중,감측인T세포표형동태변화여공능적최가시간창구위7~11 d;모형서적평균생존시간위(14.16±1.77)d。결론:NOD/SCID서통과복강주사5×107이상인PBMC가이성공건립“인-서”X-GVHD모형,7~11 d위감측인T세포표형동태변화여공능적최가시간。
Objective:To explore the suitable mouse strains,and establish stable "human-mice"X-GVHD model.Methods:This study selected the Nude Mice and NOD/SCID, and gave them sublethal dose of γ-ray irradiation whole body , and then intraperitoneal transplanted human peripheral blood mononuclear cells ( PBMC) to establish xenogeneic acute graft-versus-host disease model.By detection of human T cells in the mice′s tail venous blood,tissues,organs of the infiltration and other indicators (By flow cy-tometry and immunohistochemistry ) ,we compared the human immune cell infiltration rates in the two mouse model and recorded the survival time.Finally,we determined the appropriate strains of mice to establish X-GVHD.Optimization means were transfer ways and the appropriate amount of human PBMC ,and the best time to observe the changes of T cell phenotype and function.Results:The NOD/SCID mouse was more suitable for inducing "human-mouse"X-GVHD model,and there were no significant differences between intrap-eritoneal injection and intravenous injection.Transfer human PBMC more than 5 ×107 can establish "human-mouse"X-GVHD model.Using the optimized experimental conditions to establish the "human-mouse"X-GVHD model,we found the 7-11 days was the best time to observe the changes of T cell phenotype and function ,and the average survival time was(14.16±1.77)days.Conclusion:"Human-mice"X-GVHD model can be successfully established by intraperitoneal injection of 5×107 human PBMC into NOD/SCID, and the best time to observe the changes of T cell phenotype and function is between 7-11 days.